Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 812-713-1 | CAS number: 1219458-12-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 June 2009 - 01 July 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study has been performed according to OECD and/or EC guidelines and according to GLP principles.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF), 12 Nousan, Notification No 8147, November 2000, including the most recent partial revisions
- Deviations:
- no
- Principles of method if other than guideline:
- None.
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- 91771-18-5
- Cas Number:
- 91771-18-5
- IUPAC Name:
- 91771-18-5
- Reference substance name:
- Amines, N-(3-aminopropyl)-N (or N')-coco alkyltrimethylenedi-
- EC Number:
- 294-908-6
- EC Name:
- Amines, N-(3-aminopropyl)-N (or N')-coco alkyltrimethylenedi-
- IUPAC Name:
- 294-908-6
- Details on test material:
- - Name of test material (as cited in study report): Coco dipropylene triamine
- Substance type: Yellow clear to turbid liquid with flakes (determined at NOTOX)
- Physical state: liquid
- Analytical purity: see certificate of analysis
- Impurities (identity and concentrations): See Certificate of Analysis
- Composition of test material, percentage of components: See Certificate of Analysis
- Purity test date: See Certificate of Analysis
- Lot/batch No.: S001254
- Expiration date of the lot/batch: 4 October 2017
- Stability under test conditions: Stable
- Storage condition of test material: At room temperature in the dark under nitrogen
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- other: Crl:WI (Han)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany.
- Age at study initiation: approx. 8-10 weeks old
- Weight at study initiation: 148-183 grams. Body weight variation did not exceed +/- 20% of the sex mean.
- Fasting period before study: yes, overnight prior to dosing and until 3-4 hours after administration of the test substance
- Housing: Group housing of 3 animals per cage in labeled Macrolon cages (MIV type; height 18 cm.) containing sterilized sawdust as bedding material and paper as cage-enrichment.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period:at least 5 days before start of treatment under laboratory conditions
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19.4 – 21.0ºC
- Humidity (%): 40 - 79%
- Air changes (per hr): approx.15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 05 June 2009 To: 01 July 2009
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- propylene glycol
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 300 mg/kg: 30 mg/mL, and 50 mg/kg: 5 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg
- Justification for choice of vehicle: based on trial formulations performed at NOTOX and on test substance data supplied by the sponsor
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
DOSAGE PREPARATION (if unusual):
The formulations (w/w) were prepared within 4 hours prior to dosing, and were flushed with nitrogen. Homogeneity was accomplished to a visually acceptable level. In order to obtain homogeneity, the test substance formulations were heated in a water bath with a maximum temperature of 43ºC for a maximum of 11 minutes. The test substance (formulations) were allowed to cool down to a temperature of maximally 40ºC prior to dosing. Adjustment was made for specific gravity of the vehicle and for density of the test substance. The concentration of the test substance in vehicle was varied to allow constant dosage volume in terms of mL/kg body weight.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Based on anticipated toxicity at 2000 mg/kg. - Doses:
- 300 and 50 mg/kg
- No. of animals per sex per dose:
- 300 mg/kg: one group of 3 females
50 mg/kg: two groups of 3 females - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations: At periodic intervals on the day of dosing (Day 1) and once daily thereafter, until Day 15. Weighing: Days 1 (pre-administration), 8 and 15 and at death (if found dead after Day 1).
- Necropsy of survivors performed: yes
- Other examinations performed: none. - Statistics:
- Not applicable
Results and discussion
- Preliminary study:
- Not applicable
Effect levels
- Dose descriptor:
- LD50
- Effect level:
- > 50 - < 300 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: LD50 cut-off = 200 mg/kg bw
- Mortality:
- The incidence of mortality was as follows, presented in chronological order of treatment:
Dose level Mortality Date of treatment
300 mg/kg 3/3 05 June 2009
50 mg/kg 0/3 09 June 2009
50 mg/kg 0/3 17 June 2009
The decedents were found on Day 2 post-treatment. - Clinical signs:
- other: Animals at 300 mg/kg showed lethargy, hunched posture, uncoordinated movements, piloerection and/or ptosis prior to death. Animals at 50 mg/kg showed hunched posture, salivation, piloerection and/or rales between days 1 and 6.
- Gross pathology:
- Two animals at 300 mg/kg showed a stage of beginning autolysis, along with red foci on the glandular mucosa in one of these animals. No macroscopic abnormalities were noted in the other animal at 300 mg/kg, and in the animals at 50 mg/kg.
- Other findings:
- none.
Any other information on results incl. tables
none.
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- The oral LD50 value of Coco dipropylene triamine in Wistar rats was established to be within the range of 50-300 mg/kg body weight.
According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 200 mg/kg body weight. - Executive summary:
The acute toxicity of Cocodipropylenetriamine was determined according to OECD Guideline 423 in compliance with GLP. A group of young female rats received an oral gavage dose of the test substance in propylene glycol (10 mL/kg bw), at a dose level of 300 (one test group comprising 3 females) and 50 mg/kg bw (two test groups comprising 3 females).
The incidence of mortality was as follows, presented in chronological order of treatment:
Dose level Mortality
300 mg/kg 3/3
50 mg/kg 0/3
50 mg/kg 0/3
The decedents were found on Day 2 post-treatment.
Animals at 300 mg/kg showed lethargy, hunched posture, uncoordinated movements, piloerection and/or ptosis prior to death.
Animals at 50 mg/kg showed hunched posture, salivation, piloerection and/or rales between days 1 and 6.
Animals found dead at 300 mg/kg showed slight body weight loss.
The body weight gain shown by the animals at 50 mg/kg over the study period was considered to be normal.
Two animals at 300 mg/kg showed a stage of beginning autolysis, along with red foci on the glandular mucosa in one of these animals. No macroscopic abnormalities were noted in the other animal at 300 mg/kg, and in the animals at 50 mg/kg.
The oral LD50 value of cocodipropylene triamine in Wistar rats was established to be within the range of 50-300 mg/kg body weight.
According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 200 mg/kg body weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.